Table 1.
Clinical data
| Factors | Control group (n=41) | Observation group (n=50) | P |
|---|---|---|---|
| Gender | 0.412 | ||
| Male | 28 | 38 | |
| Female | 13 | 12 | |
| Age | 0.216 | ||
| >60 years old | 25 | 24 | |
| ≤60 years old | 16 | 26 | |
| T Stage | 0.955 | ||
| T1 | 5 | 7 | |
| T2 | 6 | 6 | |
| T3 | 16 | 18 | |
| T4 | 14 | 19 | |
| N Stage | 0.185 | ||
| N1 | 5 | 13 | |
| N2 | 19 | 23 | |
| N3 | 17 | 14 | |
| Clinical Stage | 0.442 | ||
| Stage III | 23 | 24 | |
| Stage IVa | 18 | 26 | |
| Pathological Type | 0.810 | ||
| Nonkeratinizing Squamous Cell Carcinoma | 15 | 17 | |
| Undifferentiated Squamous Cell Carcinoma | 1 | 2 | |
| Poorly Differentiated Squamous Cell Carcinoma | 15 | 15 | |
| Other Differentiated Squamous Cell Carcinoma | 10 | 16 | |
| Induction Therapy Cycle | 0.206 | ||
| 2 cycles | 11 | 8 | |
| 3 cycles | 30 | 42 |